Form D · Private Equity Fund
Akron Bioinvestments Fund II, LLC
Akron, OH · CIK 0001664992
Offering snapshot reported Jan 26, 2016 · SEC filing
- Reported sold
- $325K Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 13, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 26, 2016 | Initial | $325,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Debt, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255983
Source: Form D, filed Jan 26, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel D. De Shazior | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
202 Municipal Building 166 South High Street
Akron, OH, 44308
Akron, OH, 44308